Feasibility Study: Comparison of Performance Status With Objective Physical Activity Monitors
NCT ID: NCT01063400
Last Updated: 2012-02-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
6 participants
OBSERVATIONAL
2010-01-31
2011-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Feasibility of Exercise With Post-Op Lung Cancer Patients
NCT00636571
Surveillance For New Lung Primaries
NCT00205439
Physical Activity and Inactivity in Lung Cancer Survivors
NCT00582348
Feasibility of an Activity Regimen in Patients With Advanced Stage Lung Cancer
NCT03352245
Movement and Fitness Trackers in Determining Performance Status
NCT03971266
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Activity monitoring
Observation
monitoring of physical activity for 14 days using physical activity monitoring devices along with activity diary
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Observation
monitoring of physical activity for 14 days using physical activity monitoring devices along with activity diary
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ECOG Performance Status of 0, 1, or 2
* Prior malignancy is allowed as long as it is inactive or well-controlled without current anti-tumor therapy required
Exclusion Criteria
* Use of assistive devices (cane, crutch)
* No concurrent radiotherapy: all radiotherapy must be completed 4 weeks prior to enrollment in this study
* Patients receiving only targeted therapy are not eligible(e.g.erlotinib)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Wisconsin, Madison
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Toby Campbell, MD
Role: PRINCIPAL_INVESTIGATOR
UW Madison
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Wisconsin Carbone Cancer Center
Madison, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
OS09328
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.